Jazz Pharmaceuticals (JAZZ) Change in Receivables (2010 - 2026)
Jazz Pharmaceuticals' quarterly Change in Receivables came in at $6.5 million in Q1 2026, up 109.85% year-on-year from $3.1 million in Q1 2025, and down 90.12% quarter-over-quarter from $65.8 million in Q4 2025.
Jazz Pharmaceuticals has reported Change in Receivables for 17 years, with the latest figure at $6.5 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 109.85% year-over-year to $6.5 million; the trailing twelve-month figure through Mar 2026 stood at $178.8 million (up 435.24% YoY), and the FY2025 full-year result was $106.3 million, up 403.33% from the prior year.
- Change in Receivables for Q1 2026 stood at $6.5 million, down from $65.8 million in the prior quarter.
- The five-year high for Change in Receivables was $75.5 million in Q4 2023, with the low at -$66.0 million in Q1 2025.
- Average Change in Receivables over 5 years is $16.2 million, with a median of $9.7 million recorded in 2022.
- Peak annual rise in Change in Receivables reached 7717.25% in 2025, while the deepest fall reached 881.71% in 2025.
- Tracing JAZZ's Change in Receivables over 5 years: stood at $46.3 million in 2022, then jumped by 63.11% to $75.5 million in 2023, then tumbled by 101.14% to -$864000.0 in 2024, then soared by 7717.25% to $65.8 million in 2025, then slumped by 90.12% to $6.5 million in 2026.
- The last three Change in Receivables figures came in at $6.5 million (Q1 2026), $65.8 million (Q4 2025), and $51.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 6.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50 Mn |
| Mar 31, 2026 | 6.50 Mn |
| Dec 31, 2025 | 65.81 Mn |
| Dec 31, 2025 | 65.81 Mn |
| Sep 30, 2025 | 51.00 Mn |
| Sep 30, 2025 | 51.00 Mn |
| Jun 30, 2025 | 55.47 Mn |
| Jun 30, 2025 | 55.47 Mn |
| Mar 31, 2025 | -66.00 Mn |
| Mar 31, 2025 | -66.00 Mn |
| Dec 31, 2024 | -864,000.00 |
| Dec 31, 2024 | -864,000.00 |
| Sep 30, 2024 | 22.26 Mn |
| Sep 30, 2024 | 22.26 Mn |
| Jun 30, 2024 | -8.72 Mn |
| Jun 30, 2024 | -8.72 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 75.46 Mn |
| Dec 31, 2023 | 75.46 Mn |
| Sep 30, 2023 | 18.86 Mn |
| Sep 30, 2023 | 18.86 Mn |
| Jun 30, 2023 | -13.98 Mn |
| Jun 30, 2023 | -13.98 Mn |
| Mar 31, 2023 | -28.46 Mn |
| Mar 31, 2023 | -28.46 Mn |
| Dec 31, 2022 | 46.27 Mn |
| Dec 31, 2022 | 46.27 Mn |
| Sep 30, 2022 | 9.64 Mn |
| Sep 30, 2022 | 9.64 Mn |
| Jun 30, 2022 | 24.51 Mn |
| Jun 30, 2022 | 24.51 Mn |
| Mar 31, 2022 | 9.72 Mn |
| Mar 31, 2022 | 9.72 Mn |
| Dec 31, 2021 | 64.78 Mn |
| Dec 31, 2021 | 64.78 Mn |
| Sep 30, 2021 | -6.88 Mn |
| Sep 30, 2021 | -6.88 Mn |
| Jun 30, 2021 | 16.59 Mn |
| Jun 30, 2021 | 16.59 Mn |
| Mar 31, 2021 | 18.25 Mn |
| Mar 31, 2021 | 18.25 Mn |
| Dec 31, 2020 | 33.64 Mn |
| Dec 31, 2020 | 33.64 Mn |
| Sep 30, 2020 | 8.64 Mn |
| Sep 30, 2020 | 8.64 Mn |
| Jun 30, 2020 | 34.22 Mn |
| Jun 30, 2020 | 34.22 Mn |
| Mar 31, 2020 | -37.86 Mn |
| Mar 31, 2020 | -37.86 Mn |
| Dec 31, 2019 | 88.02 Mn |
| Dec 31, 2019 | 88.02 Mn |
| Sep 30, 2019 | -43.27 Mn |
| Sep 30, 2019 | -43.27 Mn |
| Jun 30, 2019 | -9.39 Mn |
| Jun 30, 2019 | -9.39 Mn |
| Mar 31, 2019 | 56.96 Mn |
| Mar 31, 2019 | 56.96 Mn |
| Dec 31, 2018 | -15.39 Mn |
| Dec 31, 2018 | -15.39 Mn |
| Sep 30, 2018 | 1.16 Mn |
| Sep 30, 2018 | 1.16 Mn |
| Jun 30, 2018 | -2.24 Mn |
| Jun 30, 2018 | -2.24 Mn |
| Mar 31, 2018 | 56.59 Mn |
| Mar 31, 2018 | 56.59 Mn |
| Dec 31, 2017 | -34.55 Mn |
| Dec 31, 2017 | -34.55 Mn |
| Sep 30, 2017 | 19.24 Mn |
| Sep 30, 2017 | 19.24 Mn |
| Jun 30, 2017 | -5.45 Mn |
| Jun 30, 2017 | -5.45 Mn |
| Mar 31, 2017 | 8.48 Mn |
| Mar 31, 2017 | 8.48 Mn |
| Dec 31, 2016 | -2.67 Mn |
| Dec 31, 2016 | -2.67 Mn |
| Sep 30, 2016 | 6.12 Mn |
| Sep 30, 2016 | 6.12 Mn |
| Jun 30, 2016 | 8.36 Mn |
| Jun 30, 2016 | 8.36 Mn |
| Mar 31, 2016 | 13.80 Mn |
| Mar 31, 2016 | 13.80 Mn |
| Dec 31, 2015 | 14.18 Mn |
| Dec 31, 2015 | 14.18 Mn |
| Sep 30, 2015 | 2.18 Mn |
| Sep 30, 2015 | 2.18 Mn |
| Jun 30, 2015 | 3.71 Mn |
| Jun 30, 2015 | 3.71 Mn |
| Mar 31, 2015 | 4.77 Mn |
| Mar 31, 2015 | 4.77 Mn |
| Dec 31, 2014 | 4.35 Mn |
| Dec 31, 2014 | 4.35 Mn |
| Sep 30, 2014 | 28.80 Mn |
| Sep 30, 2014 | 28.80 Mn |
| Jun 30, 2014 | 5.88 Mn |
| Jun 30, 2014 | 5.88 Mn |
| Mar 31, 2014 | 16.01 Mn |
| Mar 31, 2014 | 16.01 Mn |
| Sep 30, 2013 | 37.65 Mn |
| Sep 30, 2013 | 37.65 Mn |
| Jun 30, 2013 | 39.02 Mn |
| Jun 30, 2013 | 39.02 Mn |
| Mar 31, 2013 | 18.91 Mn |
| Mar 31, 2013 | 18.91 Mn |
| Dec 31, 2012 | -13.05 Mn |
| Dec 31, 2012 | -13.05 Mn |
| Sep 30, 2012 | 10.35 Mn |
| Sep 30, 2012 | 10.35 Mn |
| Jun 30, 2012 | -1.37 Mn |
| Jun 30, 2012 | -1.37 Mn |
| Mar 31, 2012 | 8.79 Mn |
| Mar 31, 2012 | 8.79 Mn |
| Dec 31, 2011 | 2.95 Mn |
| Dec 31, 2011 | 2.95 Mn |
| Sep 30, 2011 | 6.43 Mn |
| Sep 30, 2011 | 6.43 Mn |
| Jun 30, 2011 | 3.62 Mn |
| Jun 30, 2011 | 3.62 Mn |
| Mar 31, 2011 | -698,000.00 |
| Mar 31, 2011 | -698,000.00 |
| Dec 31, 2010 | 7.97 Mn |
| Dec 31, 2010 | 7.97 Mn |
| Sep 30, 2010 | 19,000.00 |
| Sep 30, 2010 | 19,000.00 |